nedaplatin has been researched along with Testicular Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y; Ishidoya, S; Ito, A; Kaiho, Y; Mitsuzuka, K; Miyazato, M; Nakagawa, H; Namiki, S; Ohara, S; Saito, H; Yamada, S; Yamashita, S | 1 |
| Gotoh, M; Hattori, R; Komatsu, T; Matsukawa, Y; Sassa, N; Yamamoto, T; Yoshikawa, Y; Yoshino, Y | 1 |
| Kitamura, H; Masumori, N; Matsuda, Y; Sato, S; Takahashi, S; Tanaka, T; Tsukamoto, T | 1 |
| Akaza, H; Ando, S; Kawai, K; Shimazui, T; Takaoka, E | 1 |
| Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T | 1 |
| Inoue, H; Miki, T; Mizutani, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A | 1 |
| Kotake, T; Miki, T | 1 |
| Ota, K | 1 |
| Kojima, Y; Kotake, T; Maeda, O; Miki, T; Nonomura, N; Okuyama, A; Saiki, S; Sawada, M | 1 |
| Akasaka, Y; Igarashi, H; Kondou, N; Kuroda, A; Madarame, J; Nakata, J; Ohishi, Y; Tomita, M; Yanada, S | 1 |
| Kotake, T; Miki, T; Nakagawa, S; Nakao, M; Nomoto, T; Nonomura, N; Saiki, S; Takada, T | 1 |
| Akaza, H; Aso, Y; Kotake, T; Matsumura, Y; Miki, T; Nishio, Y; Togashi, M; Yoshida, O | 1 |
| Hida, S; Okada, K; Yoshida, O | 1 |
| Akasaka, Y; Machida, T | 1 |
1 review(s) available for nedaplatin and Testicular Neoplasms
| Article | Year |
|---|---|
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
4 trial(s) available for nedaplatin and Testicular Neoplasms
| Article | Year |
|---|---|
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Topics: Acute Kidney Injury; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2007 |
[Cisplatinum compounds].
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms | 1993 |
[The salvage chemotherapy for refractory testicular cancer with novel anticancer agents].
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Humans; Irinotecan; Male; Organoplatinum Compounds; Salvage Therapy; Testicular Neoplasms | 1999 |
Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Female; Humans; Japan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Prostatic Neoplasms; Remission Induction; Testicular Neoplasms; Urologic Neoplasms | 1992 |
10 other study(ies) available for nedaplatin and Testicular Neoplasms
| Article | Year |
|---|---|
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Recurrence; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome | 2013 |
[Case report of malignant sertoli cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Combined Modality Therapy; Fatal Outcome; Humans; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Male; Orchiectomy; Organoplatinum Compounds; Salvage Therapy; Sertoli Cell Tumor; Testicular Neoplasms; Tomography, X-Ray Computed | 2008 |
[Clinical features of patients with brain metastasis from testicular germ cell tumor].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Retrospective Studies; Testicular Neoplasms; Treatment Outcome | 2010 |
Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chorionic Gonadotropin; Drug Administration Schedule; Enterocolitis, Neutropenic; gamma-Globulins; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Radiography, Abdominal; Testicular Neoplasms; Tomography, X-Ray Computed | 2006 |
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia | 2006 |
[Advantages in combination chemotherapy using the camptothecin analogue CPT-11 and cisplatinum analogues for human testicular cancer xenografts].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Administration Schedule; Drug Synergism; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Heterologous | 1993 |
Antitumor effect of CPT-11, a camptothecin derivative, on human testicular tumor xenografts in nude mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Teratocarcinoma; Testicular Neoplasms; Topoisomerase I Inhibitors; Transplantation, Heterologous; Vinblastine | 1997 |
[High-dose chemotherapy with autologous peripheral blood stem cell transfusion in the treatment of advanced testis cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1998 |
Advantages in combination chemotherapy using cisplatin and its analogues for human testicular tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Heterologous | 1990 |
[Experimental evaluation of cisplatin analogous in urogenital cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Evaluation; Humans; Kidney; Leukopenia; Male; Mice; Mice, Inbred Strains; Middle Aged; Organoplatinum Compounds; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testicular Neoplasms; Testis; Thrombocytopenia; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1989 |